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Abstract
Background: It is difficult to identify copy number variations (CNV) in normal human genomic data due to noise and non-
linear relationships between different genomic regions and signal intensity. A high-resolution array comparative genomic
hybridization (aCGH) containing 42 million probes, which is very large compared to previous arrays, was recently published.
Most existing CNV detection algorithms do not work well because of noise associated with the large amount of input data
and because most of the current methods were not designed to analyze normal human samples. Normal human genome
analysis often requires a joint approach across multiple samples. However, the majority of existing methods can only
identify CNVs from a single sample.
Methodology and Principal Findings: We developed a multi-sample-based genomic variations detector (MGVD) that uses
segmentation to identify common breakpoints across multiple samples and a k-means-based clustering strategy. Unlike
previous methods, MGVD simultaneously considers multiple samples with different genomic intensities and identifies CNVs
and CNV zones (CNVZs); CNVZ is a more precise measure of the location of a genomic variant than the CNV region (CNVR).
Conclusions and Significance: We designed a specialized algorithm to detect common CNVs from extremely high-
resolution multi-sample aCGH data. MGVD showed high sensitivity and a low false discovery rate for a simulated data set,
and outperformed most current methods when real, high-resolution HapMap datasets were analyzed. MGVD also had the
fastest runtime compared to the other algorithms evaluated when actual, high-resolution aCGH data were analyzed. The
CNVZs identified by MGVD can be used in association studies for revealing relationships between phenotypes and genomic
aberrations. Our algorithm was developed with standard C++ and is available in Linux and MS Windows format in the STL
library. It is freely available at: http://embio.yonsei.ac.kr/,Park/mgvd.php.
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Introduction
Copy number variations (CNVs) are a type of the human
genomic structural variation. CNVs are now recognized as a
major source of human genetic variability, occupying a larger
proportion of the genome than single nucleotide polymorphism
(SNP) [1]. CNV is causative of various genetic diseases including
cancer, and therefore the majority of previous association studies
have focused on domains related to cancer [2], [3]. However,
CNVs in normal human genomic structure also should be
analyzed because CNVs can exhibit different phenotypes in
different ethnic groups, sexes, or even family groups. The human
germline has been shown to possess copy number variations
despite a normal phenotype [4]. Although the mechanisms and
medical relevance of CNVs in the human genome are not yet fully
understood, a recent study focused on the relationships between
CNVs and genes as well as SNPs and genes [5].
Various CNV detection algorithms have been proposed in the
past. [6] proposed a circular binary segmentation (CBS) algorithm
that is one of the best performing algorithms with high accuracy.
However, CBS has high time complexity and was mainly designed
for cancer cell analysis. [7] provided a sensitive and robust
analytical approach for detecting CNVs but it was also designed
for cancer cells analysis with a simple threshold to determine
putative CNVs. Few algorithms have been designed for CNV
detection in normal human genomes [8], [9] although the
importance of CNV in normal human variation has been
confirmed in 2004 [10].
The resolution of most cancer and normal data used to be low.
The length of CNV is able to be several kilo base pairs or less than
it, which can be composed of only one probe in low-resolution
data while several probes in high-resolution data. Therefore,
algorithms that were designed to find CNVs based on these low-
resolution data were only suitable for identifying large-sized
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smaller than previously thought [11]. Therefore, CNV detection
algorithms have to be modified to locate small-sized CNVs. In
recent years, several algorithms have been proposed for higher
resolution data. An integrated hidden Markov model was designed
by [12] for high resolution SNP genotyping data at a kilo-level
resolution. However, this algorithm is not suitable for aCGH data
which are even higher resolutioned.
One of the best solutions for detecting small-sized CNVs is
based on high-throughput, short-read sequence data [13], [14],
[15]. However, personalized, high-throughput sequencing is still
experimentally costly. Moreover, short read alignment-based
approaches to detect CNV require extensive coverage, such as
more than 10 coverages, which can increase the cost further. For
example, 1000 genome project carried out whole genome
sequencing with from 2 to 4 coverages for 179 individuals [16],
which is not sufficient to detect CNVs. And most of the
approaches to detect CNVs with short-read sequence use an
alignment method, which requires long computational time in
building index and matching to reference. Alternatively, a few fast
and efficient methods for aCGH have been published [17], [18],
[19]. A more practical solution to detect small-sized CNVs is to
shorten the length of each probe, in other words, to increase the
resolution of the aCGH. The Wellcome Trust Sanger Institute
recently published high-resolution aCGH data. To generate this
data, the institute used 42 million probes spread across 2.1 million
probe arrays, with an average probe length of 50 bp. The
Wellcome Trust Sanger Institute published normalized intensity
data and the additional information for this dataset (http://www.
sanger.ac.uk/humgen/cnv/42mio/). All CNVs can theoretically
be detected as long as the length of each probe is less than 1 Kb,
because CNVs are defined as the gain or loss of size fragments that
are greater than 1 Kb in length [20]. Most existing CNV detection
algorithms cannot be applied to this high-resolution aCGH dataset
without modification, primarily because of their unfeasibly long
runtimes.
In aCGH data, the relationship between signal intensity and
genomic copy number is not always linear and can vary widely
according to the total DNA dosage [21]. To detect true CNV
signals, frequent random noise should be excluded and the
experimental error of the microarray should also be removed. This
is one of the limitations of aCGH data compared to sequencing
data. In particular, oligonucleotide-based high-resolution DNA
microarray are known to have a low signal to noise ratio (SNR)
[22]. Although a few of the existing CNV detection algorithms are
robust to error, they are still best suited for analyzing low
resolution data.
The aCGH data also has fundamental limitations because of its
experimental principles. In aCGH, genomic comparative hybrid-
ization is performed using two human genomes: a reference
sample and a test sample. The reference sample most commonly
used for aCGH up to this point is NA10851, which is assumed to
be normal. However, if a reference sample contains genomic
variations, then the ratio of the genomic hybridization cannot be
measured accurately. For example, if the reference sample has a
copy number loss, then the test samples would be reported as
having a gain in this area. In general, it has been assumed that the
reference sample reflects the absolutely normal and standard
status. Recently, copy number information from the reference
sample was directly used to consider the abnormality of the
reference sample [23]. By aligning short read fragments of the
NA10851 reference to a human reference genome (hg18), the
reference copy number status was inferred, and this was used to
determine the final CNVs. However, to detect real CNVs, the
authors used only 1007 candidate CNV areas from 70 individuals
composed of 42 M high-resolution aCGH results for 40
individuals [24] and 24 M aCGH results for 30 Asian individuals.
An algorithm that takes multiple samples and the effects of a
reference sample into account simultaneously has also recently
been proposed. This new, multiple sample-based approach, uses a
sparse Bayesian prior and expectation maximization algorithm to
fit the model [25].
It is increasingly important to investigate multiple human
genomes for determining genetic variations between some groups,
including different ethnic groups. There are algorithms that have
been used to detect common CNVs using a statistical frame work
[26] [27]. [26] adopts a two-step strategy that calls CNVs for
individual samples prior to cross-sample analysis. The recurrent
CNV calling approach [28] [29] [30] [31] has been criticized
based on the fact that the focus of this approach is the analysis of
high-resolution tumor-related data. Recently, whole genome
association studies have been carried out. It is essential to identity
common CNV which is altered simultaneously across multiple
samples for those association studies. We defined this common
CNV as CNVZ (CNV zone). CNVZ is slightly different from the
CNV region (CNVR) which is an area of CNVs that overlap at
least by 1 bp among all the test samples. We considered multiple
samples to be a group and analyzed the signals from all of the
samples, and then reported the identified CNV sites as CNVZs. In
other words, a CNVZ is an area that has a genomic aberration
and is determined not just by the simple union of the CNVs
detected in each sample. The main conceptual difference between
CNVR and CNVZ is the way that the boundary of the copy
number loci is defined. Conceptually, a CNVZ is a subset or
superset of a CNVR. Figure 1 shows the differences between
CNVR, CNVZ, and CNVE, as defined by [24].
In this study, we propose a novel, multi-sample-based, genomic
variation detector (MGVD) that successfully handles the huge
complexity associated with high-resolutions and the limitations of
aCGH. The proposed method identifies CNVZ using multiple
samples as a whole, and identifies CNVs from the CNVZs in
contrast to existing CNV detection methods. The key features of
MGVD are that: 1) it can be applied to both high-resolution and
low-resolution data with a reasonable runtime, 2) it directly
provides CNVZs throughout the human genome by variation
analysis, 3) it has a low false positive and negative rate, as
compared to the other algorithms used for analysis of high-
resolution aCGH data, and 4) it can be used to determine
aberrations of the reference sample by comparative assays of all
test samples.
Results
MGVD targets high resolution aCGH data, including the data
published by the Wellcome Trust Sanger Institution, which is
composed of 20 European females and 20 African females. This
data consists of 42 million probes of whole chromosomes, and is
augmented approximately 1,600 times of the first 270 array-based
HapMap samples. The machine we used for our experiments
comprised an AMD Phenom
TM II X2 545 processor, 3.0 GHz,
4 GB RAM and a 32-bit Windows 7 operating system. MGVD
was implemented in C++ with STL in Visual Studio 2005. To
determine the accuracy and runtimes of the existing algorithm,
simulated data created by [32] was used. However, this data was of
very low resolution compared to real high-resolution data. Because
MGVD is specialized for high-resolution data, the available
simulated data is not adequate for testing MGVD. We therefore
did not use Willenbrock’s simulated data to estimate the optimal
Identifying Common CNVs in Normal Human Genome
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however, we did use Willenbrock’s simulated data to prove that
MGVD works well, regardless of the resolution of the data.
Capturing the features of high resolution data and simulating the
effects of noise are some of the challenges associated with
simulation of high-resolution data. Furthermore, validation
techniques for high resolution simulated data have not yet been
established. For most of the comparisons we made, we therefore
used real data - 40 HapMap samples from the Sanger Institute and
the first Korean genome, AK1, published by the Genomic
Medicine Institute-Seoul National University. And we also used
aCGH data from 30 normal human Asian genomes [23]. The
AK1 and 30 Asian aCGH dataset are available at: http://www.
gmi.ac.kr/.
Performance of MGVD with high-resolution aCGH data
MGVD has two main parameters, hdist and hcnvz. These two
parameters were used as the cutoff threshold in each phase noted
in the Method section of this paper, and the optimal values for the
two parameters were obtained using a repetitive permutation test.
However, each chromosome had a different mean and standard
deviation of the log ratio profile and different fluctuations,
indicating that it is not reasonable to apply one static threshold
to all chromosomes. We therefore used optimal parameter values
for each chromosome that we determined by comparing the
results of our experiment with the validated results of [24].
The biologically validated results presented in [24] were based
on 40 high-resolution array CGH samples. In this study, the areas
of overlapping CNVs were merged into a CNVE if they had at
least a 51% reciprocal overlap. [24] detected 11,700 CNVs that
were greater than 443 bp, and 8,599 of these CNVEs have been
validated independently. The preliminary false discovery rate was
,20%, which was regarded as the algorithmic false rate in [24].
We also used these 40 high-resolution datasets for MGVD. We
inferred the performance of our algorithm from the validated
results based on the assumption that the 8,599 validated CNVEs
represent the true answer set.
However [24], used the genomic alteration detection algorithm
(GADA), which was proposed by [19] to detect CNVs and
biologically validated the found CNVs. Therefore, these validated
results are contingent upon the GADA. To overcome this
limitation, we compared MGVD with other algorithms using the
40 sample high-resolution dataset and also compared MGVD and
GADA with a simulated dataset and AK1 high-resolution aCGH
data. Details of these two experiments are provided in the next
sub-section.
For performance comparison of the algorithms, we calculated
the false discovery rate (FDR) and sensitivity for each chromosome. The
answer set was dependent on the dataset used. We defined these
measurements, as follows:
Sensitivity recall ðÞ ~
TPBasePairs
FNBasePairszTPBasePairs
  
FDR 1{precision ðÞ ~
FPBasePairs
FPBasePairszTPBasePairs
  
where True Positive (TP) are called when the base pairs of
identified CNVZs overlap with the base pairs of the answer set,
and False Positive(FP) are called if the base pairs of identified
Figure 1. The conceptual difference between CNVR, CNVE, and CNVZ. For three samples, the early methods detected all of the CNVs for
three samples individually. The CNVR or CNVE were determined after the CNVs were detected. The CNVR is the union of overlapping CNVs [20] and a
CNVE exists if the CNVs reciprocally overlap by more than 51% [23]. In this Figure, ‘‘CNV (s2: q)’’ represents the second CNV of sample 2. The CNVZ is
not built from individual CNVs. The start and end positions of the CNVZ are determined by the breakpoint (BP) of the segment, which is identified
from the consistency of all the samples. We defined a CNVZ as a locus where the consistency of the log ratio across all of the samples was broken and
where samples that were highly positive or negative were present.
doi:10.1371/journal.pone.0026975.g001
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true base pairs that are not detected are False Negative (FN). The
base pairs for which no CNVZs are detected and there are also no
copy number variants present in the answer set are True Negative
(TN). The distinguishing feature of our measurements is that they
are calculated using base pairs. Most previous methods used the
number of CNVs that overlapped by more than 50% with one of
the answer CNVs. However, by using a base pair approach, both
the sensitivity and FDR of the algorithm can be calculated precisely,
because only the overlapping base pairs between the CNVZ and
the answer set are considered. For example, if the CNVZ and the
true copy number of the answer set overlap by more than 50%, we
do not determine it as 1. We calculate the amount of overlapping
base pairs between them. FDR is the proportion of falsely detected
base pairs of MGVD compared to the entire number of base pairs
detected by MGVD. Sensitivity is the proportion of base pairs that
are truly detected by MGVD as compared with the true answer
set, i.e. CNVE. CNVZ and CNVE are conceptually similar. Both
indicate relatively common aberrant areas across multiple samples.
The experimental results of repetitive permutation tests to
obtain optimal values for the two parameters, hdist and hCNVZ,f o r
chromosome 22 are shown in Figure 2. In Figure 2, the two
parameters that control the trade-off between sensitivity and FDR
are adjusted in MGVD by precision versus recall operation
curves (PROC). The experimental results obtained for five
existing algorithms using their default parameters are also shown
in Figure 2. In Figure 2, the lines from MGVD_P1 to MGVD_P9
indicate the results for each parameter set. Each parameter set,
e.g. P1, P2, etc., is composed of a constant hdist value and 10
different hCNVZ values. For example, P1 has a value of 0.025 for
hdist and 10 values from 0.05 to 1.4 with intervals of 0.15 for
hCNVZ. There were nine parameter sets in total. We therefore
carried out a total of 90 different experiments by changing each
parameter.
For chromosome 22, the best parameter set was 0.5 and 0.075
for hcnvz and hdist, respectively. We found 412 CNVZs and
determined that their average length was approximately 8,410 bp
using the optimal parameter set. The largest CNVZ was
454,258 bp, and the smallest one was 506 bp. An example of
one of the CNVZ results is provided in Figure 3. This CNVZ starts
at position 22,599,808 and ends at position 22,600,400, and 13
samples participate strongly in this CNVZ.
Figure 2. PROC operational curves with 90 parameter sets for real high resolution data for chromosome 22. By varying two parameters
of MGVD, 90 different results were generated. Results for the five existing algorithms were obtained using default parameters. MGVD_P5 contains the
best parameter set.
doi:10.1371/journal.pone.0026975.g002
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We compared MGVD with the seven algorithms implemented
in CGHWeb [33], namely CBS [6], FASeg [34], cghFLasso [35],
CGHseg [36], Quantreg [37], GLAD [38], and BioHMM [39].
We ran these algorithms on chromosome 22 only, as this is the
smallest chromosome, because all seven algorithms terminated
after several days when run on data from all chromosomes. For
each algorithm, we built CNVEs from the CNVs identified from
the 40 samples. For MGVD, we did not build the CNVE, but,
instead, we used the CNVZ. The results are shown in Table 3.
The GLAD and BioHMM terminated after several days, even
when data from chromosome 22 only was used. Therefore, we
were not able to calculate the FDR and sensitivity for these two
methods, which is indicated by non/applicable (N/A) in the figure
legends. When we considered FDR and sensitivity together, then
MGVD generally outperformed the other algorithms. MGVD also
had an outstanding run time compared to the other algorithms.
MGVD processed 502,117 probes approximately 6-times faster
than the fastest of the other seven algorithms with a better FDR
and sensitivity. Furthermore, even through MGVD had the lowest
FDR, it did not have the lowest sensitivity. A low FDR indicates that
MGVD identified most of the CNVEs that were detected by the
Sanger Institute.
While CNVs are known to cover 12% of the entire genome
[20], the CNVEs that the Sanger Institute identified cover much
less, approximately 4%. Therefore, the low sensitivity and high FDR
of our algorithm are reasonable according to the Sanger Institute
findings. The low sensitivity and high FDR values that we obtained
for our algorithm indicates that it detected aberrant regions that
were not identified by [24]. However, these results do not
guarantee convergence to the correct answer, because a high FDR
can indicate an absolutely incorrect result. To compare the
performance of our algorithm with the other algorithm, we
assumed that the results obtained by [24] were the true results and
evaluated the F1 score, which is a measure of accuracy. Figure 4
shows the F1 score, sensitivity and FDR of MGVD and five other
algorithms for chromosome 22. Default parameters were used for
five other algorithms. The F1 score of MGVD was the best among
the six methods evaluated when the optimal parameters of
hdist=0.075 and hCNVZ=0.5 were used. Figure 5 shows the
maximum F1 score when we changed the hCNVZ and fixed the hdist
to the value of the x-axis. In File S1, Table 1, we present the
optimal parameter set and its F1 score and the quantitative
findings for each chromosome. We also present the experimental
results of MGVD and the five other methods for chromosome 21
in Figure S4.
Performance comparison with GADA
We compared our results with those obtained using GADA,
which is one of the fastest and recent CNV detection algorithms
with a high accuracy. We used a console version of GADA
implemented in standard C that was updated on February 11,
2008. We compared the FDR, sensitivity, and computational
runtime of the different CNV detection algorithms. Because [24]
used GADA for CNV detection before validation, the FDR and
sensitivity comparisons with our algorithm are highly dependent on
GADA. Therefore, we were not able to use the 40 high-resolution
samples for the FDR and sensitivity comparisons, but were able to
make runtime comparisons. To compare the FDR and sensitivity of
our algorithm and GADA, we ran both algorithms on the
Figure 3. An example of the CNVZ results obtained chromosome 22 using optimal parameters. The graph shown in the left-panel
indicates the raw log ratio profile pattern of CNVZ. In the left-panel and right-panel, the colored lines indicate the samples that participate in the
CNVZ. The right-panel only shows the samples that participate in the CNVZ. Among 40 samples, 13 samples are turned out to be CNVs in this result.
doi:10.1371/journal.pone.0026975.g003
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published by [40].
The simulated genome was constructed using statistical
information, such as the mean and standard deviation of the log
ratio profiles, and had several breakpoints with various lengths.
However, this simulated genomic data is shorter than real data
and does not include various complex CNV patterns that appear
in the real high-resolution aCGH data.
A Korean individual genome, known as AK1, was published
recently, representing the first whole genome analysis in Korea
and the fifth whole genome analysis in the world. To analyze the
AK1 genome, SNPs and CNVs were detected using BAC
sequencing and Agilent 24 M aCGH with Illumina BeadStudio
3.1 software.
We used the parameters reported in [24] when we applied
GADA to the simulated and AK1 datasets. We used parameter
values of hdist=0.045 and hCNVZ=0.57 when running MGVD on
the simulated data, and hdist=0.08 and hCNVZ=1.35 when running
MGVD on the AK1 data. Because MGVD was more sensitive
than GADA to the input data, we determined the best parameter
sets for these two data type. For each sample, we built CNVRs
from the CNVs GADA detected. The results are presented in
Table 4. MGVD and GADA had similar FDR values and detected
similar numbers of CNVs for the simulated dataset. The sensitivity
of GADA was higher than that of MGVD, and overall, GADA
showed better performance than MGVD for the simulate dataset.
For the AK1 datasets, GADA showed high sensitivity and FDR.
However, it detected 98% of the whole genome as CNVs while
MGVD detected only 3.4% of the whole genome as CNVs. When
we adjusted the parameter set of MGVD, the aberrant genomic
quantity became similar to that in the answer set. However, it was
not possible to find an optimal parameter set for GADA that
provided a similar genomic quantity to the answer set. We carried
out several experiments changing the parameters in GADA.
However, the identified genomic quantity was similar throughout
these experiments. GADA was not sensitive to changes in the
values of various parameters. As a result, the F1 score of GADA
was about 10 times worse than that of MGVD for the AK1 data.
The validated CNVs for the AK1 dataset cover approximately
2.75% of the entire genomic quantity of chromosome 22. This is a
relatively small portion of known CNVs and CNVE. The reason
for this is that the number of validated CNVs depends on the
algorithm or method that was used. The AK1 dataset was also
tested using 42 M aCGH data, but these results have not yet been
fully validated. There could be true CNVs that were not detected
and validated by previous studies. Furthermore, MGVD was
practically more feasible than that of GADA despite the low
number of validated CNVs that this algorithm yielded. Figure 6
shows a comparison of the computational runtimes of MGVD and
GADA for real chromosomes of various sizes.
Performance comparison with CMDS
We also compared the MGVD results with those obtained using
CMDS [28], which was recent recurrent CNV detection
algorithm. Recurrent CNVs mean the common CNVs across
multiple samples. Both MGVD and CMDS were designed to
identify common CNVs; however, CMDS did not work on 42 M
high resolution aCGH data. Therefore we used the 24 M
Figure 4. F1 score of five comparing algorithms and MGVD for chromosome 22.
doi:10.1371/journal.pone.0026975.g004
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compared the performance of MGVD and CMDS in terms of
FDR, sensitivity and F1 score. The CNVE results for the 30 Asian
aCGH dataset were reported by [23] and used these results in our
performance tests. CMDS worked with default parameter set:
block size of 50, cutoff of 10, step size of 1. We also determined the
optimal parameters of MGVD. When we used hdist=0.07 and
hCNVZ=1.0, the identified genomic quantity was similar to that of
the CNVE results for the 30 Asian samples. The F1 score of
MGVD was relatively better than that of CMDS. The results are
presented in Table 5. However, neither of the F1 scores obtained
was very high. This is because only 116 preselected CNV regions
of [23] were biologically validated with qPCR. The compassion
results between MGVD and CMDS are presented in File S2.
Average runtime of MGVD
We ran MGVD using whole chromosomes and obtained a
practical runtime for analysis of 42 M high-resolution aCGH data.
The runtime for each chromosome was derived from the optimal
threshold test, which involved 100 iterative permutation tests for
Figure 5. Maximum F1 score of MGVD for chromosome 22 according to various values of the two parameters, hdist and hCNVZ.
doi:10.1371/journal.pone.0026975.g005
Table 1. Comparison of the performance of MGVD with those of other algorithms.
Input data
Chromosome 22
40 samples
502,117probes covering an average of 50 bp/probe.
File size of raw 40 samples is about 205 MB
(35,161,372 bp per sample).
Algorithm Parameter settings
Average runtime per
sample(sec) FDR(%) sensitivity (%)
Identified
quantity (bp)
Identification ratio
(%)
MGVD hdist=0.075, hCNVZ=0.5 4.72 15.40 73.55 3,476,988 9.88
Quantreg l=1 25.06 80.32 83.67 24,793,052 80.32
cghFLasso FDR=0.05 240.26 72.57 75.61 15,448,348 72.57
CGHseg Km=20, S=20.5 424.72 86.79 66.33 31,115,147 86.79
CBS a=0.05 506.67 26.27 80.39 4,733,899 13.46
FASeg s=0.025, d=0.1, SR=50 1074.84 38.79 74.35 7,015,852 19.95
GLAD Qlambda=0.999 N/A N/A N/A N/A N/A
BioHMM Use clone distances N/A N/A N/A N/A N/A
doi:10.1371/journal.pone.0026975.t001
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phases and then took the average; the results are shown in Figure 7.
The average runtime for each chromosome was measured using
40 high-resolution aCGH datasets. The runtime was linearly
increased according to data size. All CNVZs and CNVs result for
whole chromosomes are presented in File S3.
Discussion
In this study, we developed to devise a new method to identify
CNVZs and CNVs across multiple high-resolution aCGH data
sets. We proposed a new concept, namely a common CNV
occurring area, which we called a CNVZ. Current methods detect
CNVs in various samples and then build common copy number
regions from all of the identified CNVs. However, biological
studies often require common CNV patterns detected in multiple
samples, especially when analyzing the normal human genome.
No suitable methods have been developed for this purpose, at least
not of which we are aware. By comparing all samples at a certain
locus, MGVD determines whether that locus is a genomic
aberration or not. Our experimental results demonstrated that
MGVD had an attractive computational complexity, compared
with the GADA, which is one of the fastest algorithms currently
available. The time complexity of the current methods is
proportional to the number of samples, while this is not the case
for MGVD. The sensitivity and FDR of MGVD were also
comparable with those of several other well-known algorithms.
We conducted experiments using three real datasets (the 40 high-
resolution aCGH samples, AK1 data, and Asian 30 aCGH
datasets) and one simulated dataset. MGVD is faster than the
current methods when a large number of samples are analyzed
because it uses a clustering approach, which is particularly
advantageous when detecting CNVZs using ethnic group data.
MGVD also accepts data from various platforms. For example,
MGVD can be applied to high-throughput sequencing data. To
detect CNVs using sequencing data, short reads have to be aligned
to the reference genome sequence, and then a series of alignment
scores can be obtained, similar to high-resolution aCGH data.
Materials and Methods
MGVD was designed to achieve high performance, i.e. high
accuracy and low runtime complexity, when analyzing multiple,
large, high-resolution aCGH datasets which has a low SNR, in
order to identify CNVZs across all samples at once and to identify
CNVs for each sample. MGVD consists of four major phases: (1)
smoothing the raw high-resolution aCGH data by using a moving
average during file loading, (2) making segments, (3) clustering the
samples for all of the segments, and (4) determining the CNVZs
and CNVs from the clustering results. The schematic process flow
chart of MGVD is described in Figure 8.
Notations
Table 1 summarizes some of the notations used in this paper
and provides brief descriptions of these notations. Detailed
definitions of these notations are provided in appropriate locations
in the text. Figure 9 shows several basic notations and the format
of the real data.
Raw data smoothing
High-resolution aCGH data consisting of a large number of
probes is known to have a low SNR. This results in log ratio signal
Figure 6. Comparison of the computational runtime of MGVD and GADA for five chromosomes. For each chromosome, data from 40
samples was available. We measured the total runtime with 40 samples for each chromosome. The runtimes of both MGVD and GADA increased
linearly as the data size increased. For all five various sized chromosomes of various sizes, the MGVD runtimes were shorter than the GADA runtimes.
doi:10.1371/journal.pone.0026975.g006
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therefore difficult. To eliminate these fluctuations, earlier algo-
rithms generally used smoothing methods, such as the wavelet
technique. We used a moving average to smooth the log ratio
pattern with respect to position for all of the samples simulta-
neously, because of its simplicity. We identified the optimal
window size by evaluating a variety of window sizes. The
experimental results for optimal window size are provided in
Figure S1. The optimal window size was identified as 11, which is
almost equal to the expected minimum size of a CNV, 550 bp. In
high- resolution 42 M aCGH data, one probe covers approxi-
mately 50 bp. We implemented the moving average during the file
loading phase to reduce the overall runtime. This procedure is
detailed in File S1, Table 2.
Segmentation with multiple samples
The purpose of segmentation in our approach differs from that
of existing CNV detection algorithms. In most existing algorithms,
segmentation is used to find the breakpoints to identify the CNVs
for one sample. We used segmentation to identify the points that
break the continuous consistency of the log ratio pattern across all
samples by comparing Vi and Vi+1.I fVi and Vi+1 have significantly
different log ratio patterns the (i+1) position becomes a breakpoint.
Using these breakpoints, N X M is divided into numerous
segments, SEGi,j, starting from the ith position to the jth position.
To achieve this, we computed the absolute value of Pearson’s
correlation coefficient (PCC) of all adjacent positions. We also
simultaneously calculated the Manhattan Distance (MD) between Vi
and Vi+1. These two measurements are defined as follows:
pcc(Vi,Viz1) jj ~
P N
j~1
(sj,i{Vi)(sj,iz1{Viz1)
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
P N
j~1
(sj,i{Vi)
2 P N
j~1
(sj,iz1{Viz1)
2
s
                   
                   
MD(Vi,Viz1)~
1
N
X N
j~1
sj,i{sj,iz1
       
wheresi,jisthesmoothedlogratiovalue,whichisdefinedinTable1.
The reason why we used PCC is to identify the positions that break
the consistency with respect to position. If some samples do not
follow the log ratio flow of other samples between Vi and Vi+1,t h e n
the PCC value is close to 0. If the value of PCC is close to +1, then
Figure 7. Runtime of MGVD for 40 high resolution aCGH samples. The entire runtime increased linearly with increasing data size. During the
runtime, MGVD generated CNVZs and CNVs for each sample.
doi:10.1371/journal.pone.0026975.g007
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down. However the sum of the ratio difference can be large, even if
PCC is close to +1. For example, if the PCC value of
Vi=[0,1,0,1,0,1] and Vi+1=[0,10,0,10,0,10] is 1, the sum of the
ratio difference is 27.The position (i+1) of thisexample has to be the
breakpoint because the continuous consistency is broken by the 2
th,
4
th,a n d6
th samples. As a result, the PCC is a necessary condition
but not a sufficient condition. Therefore, we also applied the MD to
identify segments. Similarly, if the value of PCCis close to 21,some
of the cases cannot be broken. For example, when Vi=[4,5,4,5,4,5]
and Vi+1=[5,4,5,4,5,4], the PCC value will be 21. However, the
actual sum of the ratio difference will not be higher than expected.
In this example, the position (i+1) does not have to be the
breakpoint. A highly negative PCC also can be used to identify
segments with MD. Therefore, we used the absolute value of the
PCC and MD tocalculate the actualdistance sum ofVi and Vi+1.T o
determine whether this point could be broken or not, we used the
following determination rule:
pcc(Vi,Viz1) jj §hpcc and MD(Vi,Viz1)vhdist?do not break
pcc(Vi,Viz1) jj vhpcc or MD(Vi,Viz1)§hdist?break
where hPCC and hdist are the criteria for deciding break-points. While
changing the hPCC, we carried out experiments to evaluate
performance for deciding the optimal hPCC. We found that, changing
the value of hPCC had a little influence on sensitivity and FDR compared
to other parameters. Sensitivity is discussed in the Results section.
Therefore, we set hPCC to 0.8 which indicates present a highly
correlated state between Vi and Vi+1. The experimental results for hPCC
a r ep r o v i d e di nF i g u r eS 2 .I nc o n c l u s i o n ,t h eNXMwas separated into
a few sub-matrices called segments, i.e. SEGi,j, by breakpoints. This
p r o c e d u r ei sd e t a i l e di nF i l eS 1 ,T a b l e3 .
Clustering for each segment
In this phase, we describe how to decide whether each segment
is candidate CNVZ or not. Samples of a segment have a
continuous and consistent log ratio. Candidate CNVZs are
determined by clustering these samples. Each SEGi,j is transformed
into an object set for clustering. The transformation is as follows:
Figure 8. Schematic Process Flow Chart of MGVD for high resolution aCGH data. MGVD consists of four phases which are sequentially
executed. We find candidates in advance through phases 1 and 2. Then we get the final results through phases 3 and 4.
doi:10.1371/journal.pone.0026975.g008
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s1,i     s1,j
s2,i     s2,j
. .
.
P . .
.
sN,i     sN,j
2
6 6 6 6 4
3
7 7 7 7 5
[O~fonjAverage of nth row : 1ƒnƒNg
where Ois the set of onwhich is the average value of the nth row in SEG.
First, we clustered the average values of each row of the N X j matrix,
each of which represents a sample. If all the elements in the N X j
matrix are used for the clustering, then some of the samples can be
included in a cluster of two or more samples, because their elements
can be partitioned into different clusters. We decided whether the
SEGi,j was a candidate for the CNVZ or not without taking into
consideration multiple clusters for one sample. Then, we carried out k-
means clustering, which is a fast and typical partitioning-based method.
We assumed that one segment could probabilistically have three
states on their samples: gain, neutral, and loss. It might be argued
that there are more states than the three that we assumed, such as
outlier and high gain states. However, outliers without their own
state are removed by k-means clustering. Furthermore, high gain or
extreme loss states can be included as gain and loss states,
respectively. Thus there are only three states in total. Based on this
reasoning, we do not need to find the optimal k when evaluating
the clustering model with AIC or BIC. We therefore fixed k to 3.
Furthermore, we do not have to allow for non-convex shapes
because our objects are in 1-dimensional space. With these
constraints, we applied k-means clustering to partitioning the
segments.
The time complexity of k-means clustering is O(mkt), where m is
the number of objects, k is the number of clusters, and t is the
number of iterations. In our method, the values of m and k are
Figure 9. Multi-sample aCGH data and notations used in this paper. Descriptions of the notations used in the paper are provided in Table 1.
The left, black-dotted rectangle containing si,j indicates the window used for the moving average. The right, dotted, red rectangle indicates a
segment.
doi:10.1371/journal.pone.0026975.g009
Table 2. The sensitivity and FDR dependence of the algorithms on the data type.
Data
Simulated dataset [32]
(500 probes620 samples)
Chromosome 22 of AK1 [40]
(Nimblegen 42 M high-resolution)
Answer set
Five CNVs
(composed of 92 probes) 28 CNVs (Quantity is 967,462 bp)
Method MGVD GADA MGVD GADA
sensitivity (%) 89.13 100.00 70.92 98.97
FDR (%) 8.88 8.91 41.50 97.17
F1 score 0.90 0.95 0.64 0.06
Identified quantity (bp) 90 probes 101 probes 1,197,547 34,606,907
Identification ratio (%) 18.00 20.20 3.40 98.42
Average length of detected CNVs 8.1 probes 20.2 probes 16,183 bp 96,130 bp
doi:10.1371/journal.pone.0026975.t002
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We performed clustering for all of the segments. However, because
the number of segments, m, was much less than the number of all
of the positions, M, the entire algorithm was executed in a
reasonable amount of time. Our k-means clustering procedure is
detailed in File S1, Table 4.
Determination of CNVZs and CNVs
We identified CNVZs and CNVs by analyzing the distributions
of three clusters for each segment. To determine CNVZs, we
defined a scoring function that is based on the distance among
centroids and can be used to analyze various cluster distributions.
Basically, each sample can have a variation or neutral state in a
segment. Sometimes, numerous CNVs occur simultaneously
across all samples. The scoring function was designed to consider
all these possible distributions of clusters in a segment. Figure 10
shows three possible cluster distributions.
We identified whether the region of a segment was an
aberration or not by evaluating the distances between all possible
pairs of clusters in the segment. For example, if one segment has a
large sum of distances between possible pairs of clusters, then these
clusters are located far away from each other. In this case, the
segment is likely to be judged to be a CNVZ. By using only the
distance sum of possible cluster pairs, however, aberrations cannot
be detected in some cases, such as in segment 3 in Figure 10.
Segment 3 has a small distance among centroids in contrast to the
other cases, but its objects have a highly negative log ratio with
little variation among the objects; therefore, Segment 3 can be
considered a CNVZ. To solve the problem noted above, we used
the following the scoring function:
f(CLUi)~ r jj f dist(clu1,clu2)zdist(clu1,clu3)zdist(clu2,clu3)g
where dist() is the distance between two centroids of CLUi. If these
three clusters are close to each other, the sum of distances is small.
If the value of f(CLUi) is high, then CLUi is determined to be a
CNVZ. However, the sum of all of the distances alone cannot
cover all of the possible clustering cases. For example, all the
clusters of segment 3 in Figure 10 are close to each other, and all
the centroids are highly negative. However, according to f(CLUi),
segment 3 could be a neutral area, because the sum of all the
distances is low. Segment 3 cannot be distinguished from real a
neutral area where all the centroids of clusters are located around
the zero log ratio profile. Therefore, in this case, the score is
weighted to reduce the false rate.
The weight, r, is the sum of flags, where flag M {1, 0, 21}. Let m
and s be the mean and standard deviation of all the centroids for
all the segments, respectively. We assume that a cluster whose
absolute centroid value is greater than m+s can be considered to
be out of a neutral position. According to our assumption, the flag
is calculated as follows:
flag~
1, centroid valuew0 and centriod valuewmzs
{1, centroid valuev0 and centriod valuevm-s
0, otherwise
8
> <
> :
9
> =
> ;
For example, if we assume that a set of centroids of CLUn is {23,
24, 22} and that m+s is 1, then r will be 23. As another
example, if there is a set of centroids that is {23, 24, 2}, then r
will be 21, because r is the sum of 22 and 1.
The segment with hcnvz,f(CLUi),houtlier is selected as a candidate
CNVZ. Here, hcnvz is the threshold to determine a candidate
CNVZ and houtlier is the threshold used to trim outlier segments
with a very high value of f(CLUi). One of these two parameters,
houtlier, is not sensitive to performance if it is larger than a certain
value. Because most samples have similar log ratio distributions
and outliers have extremely high or low log ratios, we can
determine the optimal criterion for pruning outliers. We set houtlier
to 3.5. The experimental results for houtlier are provided in Figure
S3.
To estimate the CNVs for each sample, we identified samples
that participate in CNVZ. After identifying all the CNVs for each
sample, we merged and pruned the CNVs to build the final set of
CNVs for each sample. Finally, the candidate CNVZs were also
merged and pruned. The adjacent candidate CNVZs were
merged into a large CNVZ if their interval was less than 1 Kbp.
The segmentation phase of our algorithm identifies short
segments, ,0.5 Kbp. However, these segments can be disre-
garded, because the minimum CNV size is approximately
0.5 Kbp in the NimbleGen aCGH dataset. Through these two
post processes, the final CNVZs were identified and the
segmentation process, which is closely related to the breakpoint
decisions, was supplemented. As a result, those processes play a
role in maximizing the length and accuracy of CNVZs. The
algorithm for determining CNVZs and CNVs is shown in File S1,
Table 5.
Table 3. Performance comparison of MGVD and CMDS.
Data
Chromosome 22 of Asian 30 [23]
(Agilent 24 M high-resolution)
File size of the 30 raw samples is
about 76 MB
(35,136,378 bp per sample)
Answer set 104 CNVE (6,846,363 bp)
Method MGVD CMDS
sensitivity (%) 48.41 14.38
FDR (%) 45.50 40.93
F1 score 0.51 0.23
Identified quantity (bp) 6,081,610 1,667,547
Identification ratio (%) 17.30 4.74
Average length of recurrent CNV
(bp)
17,376 13,781
Max length of recurrent CNV (bp) 371,559 515,022
Min length of recurrent CNV (bp) 503 928
Runtime (min9 sec0)1 9120 19330
doi:10.1371/journal.pone.0026975.t003
Table 4. Notations used throughout the manuscript.
Symbol Definition
NXM Raw input data matrix composed of N samples and M positions
ri,j A raw log ratio of the ith sample in the jth position
si,j A smoothed log ratio of the ith sample in the jth position
Vi A NX1sub-matrix at the ith position in the NXMmatrix
SEGi,j A NXjsub-matrix from the ith to the jth position
CLUi A set of clusters in the ith segment
CZi,j A CNVZ from the ith to the jth position
doi:10.1371/journal.pone.0026975.t004
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Our approach can identify CNVZs taking into consideration
aberrations of the reference sample by using comparative assays
for all test samples. A recent study categorized CNV calls into
three possible cases: obscure, covert and overt [23]. An obscure
call means that the test sample will come out having a copy
number but this is caused by an aberration in the reference
sample. If the reference sample has a complete loss, the test sample
is reported to have a high gain. In this case, however, the test
sample should be neutral. A covert call means that the status of the
reference and test sample have the same copy number variation,
i.e. either both are gains or both are losses, therefore the test
sample will end up as neutral. An overt call indicates that the
reference sample does not have copy number variation. This is the
basic assumption in most studies. Details of these three categories
are provided in Table 2.
Of the three categories represented in Table 2, obscure calls can
be detected by our approach. Here, overt calls are exceptional
because they are a basic assumption of the aCGH platform. It is
impossible to call covert CNVs using our algorithm because it does
Table 5. Three categories of CNV calls proposed by [23].
Call categories Case ID Status of the reference sample Status of the test sample
Ostensible result/True
result
Can be solved by
MGVD?
Obscure case1 Complete Loss Very high and unstable CNV/Neutral O
case2 Heterozygous Copy Number:
loss(1 copy), gain
Heterozygous Copy
Number: gain, loss
CNV/CNV O
Covert case3 Copy Number: loss, gain Copy Number: loss, gain Neutral/CNV X
Overt case4 Normal Copy Number CNV/CNV Not required
doi:10.1371/journal.pone.0026975.t005
Figure 10. Three possible distributions of clusters. It would be problematic to just consider the distances between clusters. The gray circle
indicates the objects in a cluster, and the black circle indicates the centroid of a cluster. This is a conceptual figure to explain the various relationships
among clusters.
doi:10.1371/journal.pone.0026975.g010
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tion from the reference sample. Our algorithm uses only the
distribution of clusters to estimate the reference copy number.
Obscure calls are false positive results due to a discrepancy
related to the reference copy number. There are two sub-
categories of obscure call: one due to complete loss and the other
to a heterozygous copy number. The two sub-categories, case 1
and case 2, are shown in Table 2. To detect these cases without
reference sample sequencing, we inferred the reference copy
number by analyzing CNVZs as follows.
First, if the centroid of one cluster of a CNVZ has a high ratio
profile and those of the other two clusters are also somewhat high,
the value of f(CLUi) will be large. However, if the value of f(CLUi)i s
higher than houtlier, this CNVZ will be identified as a neutral outlier.
We assumed that the appearance of the cluster with a high
centroid was caused by a complete loss in the reference. In
Figure 11, the left panel notated [A] shows the simple principle
underlying our proposed method.
Second, if the three clusters of a segment are widely spread
without satisfying the outlier condition, this segment is identified as
a CNVZ. In this case, however, the reference sample might be said
to have a copy number variation. In our algorithm, if the reference
has a heterozygous copy number compared to the test sample, the
true result is adjusted. In the example shown in the right panel of
Figure 11, the reference sample has a loss, therefore the centroids
of the three clusters must be lower and vice versa. Nevertheless,
both of these two cases will be identified as CNVZ by our
algorithm. When all the clusters of a CNVZ are far away from the
medium cluster, whose centroid is nearby zero, that CNVZ will be
detected as a CNVZ despite the heterozygous copy number of the
reference sample.
Supporting Information
Figure S1 F1 score according to window size. While
changing the window size from 7 to 16, we also changed hCNVZ from
0.4 to 0.85. The graph shows the maximum, minimum and
average f1 scores when we change the parameters. The horizontal
bar for each window size indicates the average f1 score and it was
maximal at window size 11. Therefore, we decided the optimal
window size to be 11.
(TIF)
Figure S2 F1 score according to hPCC. While changing the
hPCC from 0.4 to 0.85, we also changed hCNVZ from 0.4 to 0.85.
The graph shows the maximum, minimum and average f1 scores
when we change the parameters. The horizontal bar for each hPCC
indicates the average f1 score. If we use the large value for hPCC,
which is close to 1, the size of the segment will increase, while the
number of segments will decrease. It may slow down the
performance because we have to find small sized CNVZ.
Therefore, we decided the optimal hPCC to be 0.8 which is clearly
distinguished from the previous ones and which is not too close to
the larger value, 1.
(TIF)
Figure S3 F1 Score according to houtlier. While changing the
houtlier from 1.5 to 6, we also changed hCNVZ from 0.05 to 1.4. The
graph shows the maximum, minimum and average f1 scores when
we change the parameters. The horizontal bar of each houtlier
means the average f1 score. If we use a value which is larger than
3.5 as houtlier, the f1 score is in equilibrium condition. Therefore, we
decide the optimal houtlier to be 3.5.
(TIF)
Figure 11. Schemes to consider the reference copy number in MGVD. The left Figure [A] indicates case 1, which has a complete loss in the
reference. MGVD detects these cases as neutral. The right Figure [B] indicates case 2, which has a heterozygous copy number compared with the test
sample. MGVD detects these cases as CNVZs.
doi:10.1371/journal.pone.0026975.g011
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MGVD on chromosome 21.
(TIF)
File S1 Five supplemental tables.
(DOC)
File S2 Comparison results of our method and CMDS
using the 30 Asian aCGH datasets.
(XLS)
File S3 CNVZ results identified by our method for
whole chromosome.
(XLS)
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